Among 132 FAP-a positive DCIS patients, 41 recurred to DCIS, 52 recurred, and progressed into invasive breast cancer, while the remaining 39 cases experienced no recurrence. The gene discussed is FAP; the disease is ductal breast carcinoma in situ.